跳至主要内容
临床试验/NCT03169270
NCT03169270已完成不适用

Muscular Adaptations After Endurance Exercise Training in Patients With COPD

Hospital Clinic of Barcelona0 个研究点目标入组 26 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26
主要终点
Muscle oxygen saturation (StO2)

研究概览

简要总结

The current protocol is developed in the context of a large Research and Innovation (R&I) program aiming the promotion of daily life physical activity in chronic patients registered at clinicaltrials.gov (NCT02976064) and approved by the ethical committee of the Hospital Clinic de Barcelona (HCB/2016/0883). The project is partly supported by the Smart Innovation Strategies promoted by the EU Commission (COMRDI15-1-0016). Specifically, the protocol uses retrospective information collected between 2005-2008 as part of the EU project Biobridge (LSHG-CT-2006-037939).

The aims of the current analysis of the retrospective information are 1) to assess training-induced changes in muscle oxygen saturation (StO2) assessed by near-infrared spectroscopy (NIRS) during constant-work rate cycling exercise (CWRE) as a useful marker of the effects of training at limb muscle level in patients with chronic obstructive pulmonary disease (COPD), and 2) to further explore underlying mechanisms of skeletal muscle dysfunction as a characteristic systemic effect of COPD, potentially modifiable with preventive interventions as endurance muscle training.

Methods: Incremental exercise (VO2 peak) and CWRE at 70% baseline peak work rate, before and after 8-week of endurance exercise training, were done in healthy sedentary subjects and COPD patients. NIRS was used to assess StO2 in the left "vastus internus" during the CWRE (before an after training program) (objective 1); and blood samples and muscle biopsies of the quadriceps were obtained at rest (before an after training program) (objective 2).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COPD diagnosis following GOLD criteria (FEV1/FVC post-broncodilator <0,7)
  • Clinical stability for at least 3 months

排除标准

  • Age <45 years
  • Any active cancer
  • Comorbidities which carry high-level of handicap
  • Other respiratory disease than COPD
  • No sign of informed consent

结局指标

主要结局

Muscle oxygen saturation (StO2)

时间窗: Baseline - 8 weeks

Near-infrared spectroscopy (NIRS)

Skeletal muscle dysfunction

时间窗: Baseline - 8 weeks

Quadriceps muscle biopsies

次要结局

  • Systemic effects of COPD(Baseline - 8 weeks)
  • Maximal cardiopulmonary response to exercise training(Baseline - 8 weeks)
  • Submaximal cardiopulmonary response to exercise training(Baseline - 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Josep Roca

Consultor senior

Hospital Clinic of Barcelona

相似试验